Findings seen for lipoprotein a, remnant cholesterol, and high-sensitivity C-reactive protein.

Rilparencel, a percutaneous minimally invasive injectable product prepared from patients’ own kidney cells, is being developed to treat those with stage 3b or 4 CKD and either type 1 or type 2 ...

Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.

A phase 2 RCT evaluated progression of prostate-specific antigen and urinary symptoms in men with low-risk prostate cancer who were administered phytochemical-rich food and Lactobacillus probiotic ...

No significant increase in hazard ratios seen for GI events for semaglutide versus dulaglutide, tirzepatide versus dulaglutide, tirzepatide versus semaglutide.

Povetacicept is an investigational dual BAFF and APRIL inhibitor being tested for various glomerulonephritis types in clinical trials.

Past-month alcohol consumption and believing cancer is not preventable linked to belief that alcohol has no impact on cancer risk.

Cigarette smoking decreased from 42 percent in 1965 to 11.5 percent in 2023; few eligible adults are up to date with lung cancer screening.

Source: Getty Images To improve patient outcomes, therapeutic diets need to be about nourishment, not restriction or fear. For decades, the “renal diet” has been a standard part of chronic kidney ...

The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.